Epigenetic Deregulation of Apoptosis in Cancers by Ezgi Ozyerli-Goknar, Tugba Bagci-Onder

Get full text

<i>IDH</i> Mutations in Glioma: Double-Edged Sword in Clinical Applications? by Alisan Kayabolen, Ebru Yilmaz, Tugba Bagci-Onder

Get full text

Examining the role of chromatin modifying enzymes in medulloblastoma by utilizing a chemical library by Lokumcu, T, Senbabaoglu, F, Oppermann, U, Bagci-Onder, T

Assessing the function of chromatin modifying enzymes in medulloblastoma by Lokumcu, T, Senbabaoglu, F, Oppermann, U, Bagci-Onder, T

Editorial: Cell Death and Targeted Cancer Therapies by Tugba Bagci-Onder, Ozgur Kutuk, Triona Ni Chonghaile, Uwe Knippschild

Get full text

Evaluating the effect of therapeutic stem cells on TRAIL resistant and sensitive medulloblastomas. by Irina Nesterenko, Simone Wanningen, Tugba Bagci-Onder, Maarten Anderegg, Khalid Shah

Get full text

Tumor Cell Infiltration into the Brain in Glioblastoma: From Mechanisms to Clinical Perspectives by Fidan Seker-Polat, Nareg Pinarbasi Degirmenci, Ihsan Solaroglu, Tugba Bagci-Onder

Get full text

Glioma-on-a-Chip Models by Merve Ustun, Sajjad Rahmani Dabbagh, Irem Sultan Ilci, Tugba Bagci-Onder, Savas Tasoglu

Get full text

Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma by Filiz Senbabaoglu, Filiz Senbabaoglu, Ali Cenk Aksu, Ali Cenk Aksu, Ahmet Cingoz, Ahmet Cingoz, Fidan Seker-Polat, Fidan Seker-Polat, Esra Borklu-Yucel, İhsan Solaroglu, İhsan Solaroglu, İhsan Solaroglu, Tugba Bagci-Onder, Tugba Bagci-Onder

Get full text

Chronically Radiation-Exposed Survivor Glioblastoma Cells Display Poor Response to Chk1 Inhibition under Hypoxia by Nareg Pinarbasi-Degirmenci, Ilknur Sur-Erdem, Vuslat Akcay, Yasemin Bolukbasi, Ugur Selek, Ihsan Solaroglu, Tugba Bagci-Onder

Get full text

Exploiting epigenetic targets to overcome taxane resistance in prostate cancer by Buse Cevatemre, Ipek Bulut, Beyza Dedeoglu, Arda Isiklar, Hamzah Syed, Ozlem Yedier Bayram, Tugba Bagci-Onder, Ceyda Acilan

Get full text

Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer by Saraç, H, Morova, T, Pires, E, McCullagh, J, Kaplan, A, Cingöz, A, Bagci-Onder, T, Önder, T, Kawamura, A, Lack, NA

Engineering human stellate cells for beta cell replacement therapy promotes in vivo recruitment of regulatory T cells by D.C. Oran, T. Lokumcu, Y. Inceoglu, M.B. Akolpoglu, O. Albayrak, T. Bal, M. Kurtoglu, M. Erkan, F. Can, T. Bagci-Onder, S. Kizilel

Get full text

New trends in cell death: overview of the International Society of Cell Death (ICDS) annual meeting in Johannesburg South Africa (May 19-22, 2023) by Marianne J. Cronjé, Varsha Gadiyar, Jerry Edward Chipuk, Tugba Bagci-Onder, Dmitri Krysko, Raymond B. Birge, Richard A. Lockshin, Zahra Zakeri

Get full text

Parameters Influencing Gene Delivery Efficiency of PEGylated Chitosan Nanoparticles: Experimental and Modeling Approach by Nihal Olcay Dogan, Ugur Bozuyuk, Pelin Erkoc, Alp Can Karacakol, Ahmet Cingoz, Fidan Seker-Polat, Muhammad Anwaar Nazeer, Metin Sitti, Tugba Bagci-Onder, Seda Kizilel

Get full text

Identification of <i>SERPINE1</i> as a Regulator of Glioblastoma Cell Dispersal with Transcriptome Profiling by Fidan Seker, Ahmet Cingoz, İlknur Sur-Erdem, Nazli Erguder, Alp Erkent, Fırat Uyulur, Myvizhi Esai Selvan, Zeynep Hülya Gümüş, Mehmet Gönen, Halil Bayraktar, Hiroaki Wakimoto, Tugba Bagci-Onder

Get full text

The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma by Ozyerli-Goknar, E, Sur-Erdem, I, Seker, F, Cingöz, A, Kayabolen, A, Kahya, Z, Uyulur, F, Gezen, M, Tolay, N, Erman, B, Gönen, M, Dunford, J, Oppermann, U, Bagci-Onder, T

EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities by Yedier-Bayram, O, Gokbayrak, B, Kayabolen, A, Aksu, AC, Cavga, AD, Cingöz, A, Kala, EY, Karabiyik, G, Günsay, R, Esin, B, Morova, T, Uyulur, F, Syed, H, Philpott, M, Cribbs, AP, Kung, SHY, Lack, NA, Onder, TT, Bagci-Onder, T

Experimental data on novel Fe(III)-complexes containing phenanthroline derivatives for their anticancer properties by Cristina P. Matos, Zelal Adiguzel, Yasemin Yildizhan, Buse Cevatemre, Tugba Bagci-Onder, Ozge Cevik, Patrique Nunes, Liliana P. Ferreira, Maria Deus Carvalho, Débora L. Campos, Fernando R. Pavan, João Costa Pessoa, Maria Helena Garcia, Ana Isabel Tomaz, Isabel Correia, Ceyda Acilan

Get full text

Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival by Ozyerli-Goknar, E, Kala, EY, Aksu, AC, Bulut, I, Cingöz, A, Nizamuddin, S, Biniossek, M, Seker-Polat, F, Morova, T, Aztekin, C, Kung, SHY, Syed, H, Tuncbag, N, Gönen, M, Philpott, M, Cribbs, AP, Acilan, C, Lack, NA, Onder, TT, Timmers, HTM, Bagci-Onder, T